-
Study aim
-
Determination of the effect of ketamine-midazolam combination in pain management at emergency department with regard to ketamine adverse reactions when used alone and comparison of these two regimens with morphine
-
Design
-
In this double blind clinical trial study there are three study regimens:ketamine-midazolam, ketamine, and morphine which are used as pain management at emergency department in patients with moderate to severe pain. 168 patients according to the inclusion and excluding criteria enter the study and will be randomized by specifying a code and use of randomized numeric table.
-
Settings and conduct
-
patients are selected at emergency department who have moderate to severe pain. study regimens are prefilled in syringes with special blinded codes administered to the patients by the nurse.
-
Participants/Inclusion and exclusion criteria
-
inclusion criteria:Patients with acute pain (onset within a week) including traumatic pain, non-traumatic musculoskeletal pain, neuropathic pain, low back pain, pain due to renal stone with with severity of point 5 or greater in numeric rating scale who need morphine for pain reduction, age range:18 to 55 yrs,
exclusion criteria: pregnancy and lactation, allergy to morphine, ketamin and midazolam, brain problems, wight less than 46 or greater than 115 kg, unstable vital signs, elevated ICP, chronic pain, renal or hepatic failure, alcohol or substance abuse.
-
Intervention groups
-
1-midazolam-ketamine, 2-ketamine, 3-morphine
-
Main outcome variables
-
1-pain level 2- adverse reactions
Main outcome is the level of pain reduction in three study groups at 15,30,45,60, and 90 minutes post drug administration.
Adverse reaction incidence is compared between the three groups.